Hey there, bargain hunter.

Here is a question worth sitting with: when a software company loses 85% of its market value from peak, turns GAAP profitable for the first time in its history, and then quietly doubles off the lows while most investors are still talking about it in the past tense, is that a bargain, or is it a momentum story wearing a value disguise?

That is the UiPath (NYSE: PATH) question. And it is sharper than most coverage suggests, because the easy answer in both directions is wrong.

The Scoreboard

Let us start with the facts on the ground, because the price action alone tells a story about perception shifting.

• 52-week range: $9.20 to $19.84. Current price: approximately $16.03 as of August 15, 2026.
• Move off the lows: Roughly 75% since the trough. The stock climbed from approximately $10.20 to the mid-$16s over six weeks, with shallow pullbacks and consistent bid support.
• Three-month return: Up approximately 52%, one of the stronger moves in enterprise software over that window.
• Market cap: Approximately $8.3 billion. Net cash position: approximately $1.3 billion.
• All-time high closing price: $85.12, set in May 2021. Current price is 81% below that peak.
• Analyst consensus: Hold, with an average price target near $13 to $14, a figure the stock has already cleared.

That last point is worth underlining. Wall Street’s consensus target is below where the stock is trading today. The market has moved faster than the analyst community. That gap is either an opportunity or a warning, depending on what the fundamentals actually support.

The Real Reason the Stock Was Discounted

To understand whether PATH is cheap today, you need to understand why it was punished so severely in the first place. The bear case that drove the stock to $9 was not irrational. It had three legitimate components.

First, UiPath’s growth decelerated sharply from the COVID-era surge. The company went from being a hypergrowth RPA vendor posting 50%-plus annual revenue gains to a mid-teens grower. That deceleration was real, and the multiple compression that followed was proportionate to it.

Second, the competitive threat from hyperscalers looked existential to many investors. Microsoft, Google, and Amazon were all building agent-based automation tools, often bundled into infrastructure contracts enterprises were already signed into. If those bundles were good enough, UiPath’s standalone platform looked redundant.

Third, UiPath burned through years without GAAP profitability, even as revenue scaled. For a software company with 83% gross margins, persistent operating losses raised questions about cost discipline and the long-term economics of the business model.

All three concerns were legitimate. The question the market got wrong was whether they were permanent or temporary. Evidence now suggests the answer, at least partially, is the latter. But the evidence is not yet conclusive, and that ambiguity is exactly where a value investor should be paying attention.

What UiPath Actually Is: The Deep Dive

UiPath is not an RPA vendor the way Bloomberg is a data terminal. The description has not been accurate for at least two years, and continuing to use it is how analysts miss the transition.

The company describes itself as a global leader in agentic business orchestration. What that means in practice: UiPath’s Maestro platform coordinates AI agents, traditional software robots, and human workers across end-to-end enterprise workflows. Maestro does not just run a bot that fills out a form. It models entire processes, routes exceptions to human reviewers, monitors KPIs in real time, maintains a governance log that regulators can audit, and integrates across OpenAI, Azure AI Foundry, Google Gemini, and NVIDIA foundation models.

That governance and auditability layer is the competitive differentiator most financial media underweights. Enterprises, particularly in financial services and healthcare, are not hesitating to deploy AI because they doubt the technology. They are hesitating because they cannot explain what an agent did when something goes wrong, and regulators can and will ask. UiPath’s AI Trust Layer, OpenTelemetry-compliant tracing, and audit capabilities address that hesitation directly.

UiPath was named a Leader in the Forrester Wave for Document Mining and Analytics Platforms in Q2 2026, earning the highest possible scores in agentic AI operations, functionality, and integration. That is not a vanity award. Forrester Wave placements influence enterprise procurement decisions, and a top placement in agentic AI criteria is directly relevant to where the company is pointing its growth.

The vertical expansion is accelerating. In April 2026, UiPath announced agentic AI solutions for financial services, retail, and enterprise operations at its Agentic Summit, covering financial crime compliance, loan origination, purchase-to-pay, retail merchandising, and inventory management. The WorkFusion acquisition, which brought AI agents for financial crime compliance into the platform, is already producing measurable customer results: Valley National Bank automated 61% of sanction-hit reviews and processes approximately 14,000 alerts monthly, reducing manual research time from 10 to 20 minutes per alert down to roughly 1 to 2 minutes. That is the kind of concrete ROI number that enterprise procurement committees need to see before writing a larger check.

In May 2026, UiPath extended agentic AI capabilities to its on-premises Automation Suite, specifically targeting government agencies and regulated industries with strict data sovereignty requirements. That move opens a customer segment, federal and state government, where most cloud-native competitors cannot yet go.

The Data Section

This is where bargain hunters do their work. Let us go through the numbers methodically, because the story is in the details, not the headline.

Revenue and Growth

• Full fiscal year 2026 (ended January 31, 2026): Revenue of $1.611 billion, up 13% year over year.
• Q1 fiscal 2027 (ended April 30, 2026): Revenue of $418 million, up 17% year over year.
• Full-year FY2027 guidance: $1.776 billion to $1.781 billion, implying approximately 10% to 11% growth on the full-year base.
• Q2 FY2027 guidance: $395 million to $400 million.

ARR and Customer Metrics

• ARR as of Q1 FY2027: $1.901 billion, up 12% year over year.
• Q2 FY2027 ARR guidance: $1.929 billion to $1.934 billion.
• Full-year FY2027 ARR target: $2.058 billion to $2.063 billion.
• Net dollar retention rate: 109% in Q1 FY2027, improving sequentially.
• Customers with more than $1 million in ARR: 374, up 18% year over year.
• Customers above $100,000 in ARR: 2,620, up 11%.
• Total customers: approximately 10,600.
• Fortune 500 penetration: approximately 65% of the Fortune 500 in the customer base.

Profitability and Cash Flow

• Gross margin: 83% GAAP, 85% non-GAAP, consistent and high.
• Q1 FY2027 GAAP operating income: $28 million, versus a loss of $16 million a year earlier. First GAAP-profitable quarter.
• Full fiscal year 2026: GAAP operating income of $57 million, the first full year of GAAP profitability in company history.
• Non-GAAP operating income FY2026: $370 million. FY2027 guidance: approximately $430 million.
• Trailing twelve-month free cash flow: approximately $375 million.
• Net cash position: approximately $1.3 billion, with minimal debt.

The AI Deal Signal

The metric that matters most is not in the income statement. In Q1 FY2027, 16 out of UiPath’s top 20 deals included AI components. Expansions that included AI were six times larger than those that did not. That ratio is a revenue structure shift. As AI penetrates the existing install base, average contract sizes expand. The growth is not coming from winning new logos alone. It is coming from deepening the relationship with the 10,600 customers already on the platform.

Remaining performance obligations grew 15% to $1.413 billion. That is a forward bookings indicator. It tends to precede recognized revenue by two to four quarters, and a 15% growth rate in RPO at the current stage of the company’s maturity is a constructive signal.

Is It Cheap? The Valuation Examination

This is the crux. And the honest answer is: it depends on which lens you use, which is exactly where a disciplined investor needs to slow down.

What the Multiples Say

• Trailing P/E: Approximately 21x, down dramatically from the triple-digit multiples of 2022 and 2023.
• Forward P/E: Approximately 15x on forward estimates.
• PEG ratio: Approximately 0.63. Below 1.0 typically signals a stock is cheap relative to its growth rate.
• EV/FCF: Approximately 14.5x on trailing free cash flow of $375 million. For a software business with 83% gross margins, that is not an expensive number.
• EV/Sales: Approximately 3.3x as of late July 2026.
• Short interest: 21.8% of shares outstanding. Elevated short interest in a stock that has already climbed 75% off its lows creates a mechanical tailwind if results accelerate. It also reflects genuine skepticism from sophisticated investors who have done the work.

Relative to the software peer group, PATH’s price-to-free-cash-flow is cheaper than roughly 82% of comparable companies in the same industry. The PEG ratio, which adjusts the earnings multiple for expected growth, sits below 1.0. By those metrics, PATH screens as undervalued relative to peers.

But context matters. The stock has already moved 75% off its lows. Some of that valuation improvement is already in the price. The forward P/E of 15x is only a bargain if the earnings estimates prove conservative. If ARR growth stalls or the Q2 guide disappoints, the multiple expands rather than compresses, and suddenly 15x forward earnings looks expensive again.

The valuation is not obviously cheap in the way a stock at 5x earnings with a pristine balance sheet is cheap. It is conditionally cheap: inexpensive if the company executes, fair value or worse if it does not. That distinction matters for position sizing and patience.

Cheap, Fairly Valued, or a Value Trap?

This is the defining question, and it deserves a direct answer.

PATH is not a value trap. A value trap is a business with deteriorating fundamentals that looks inexpensive on historical metrics but is actually in secular decline. UiPath is growing revenue in the mid-teens, expanding GAAP margins, generating real free cash flow, and building a product that addresses one of the most durable enterprise spending priorities of the decade: automating knowledge work. The core business is not broken.

PATH is not obviously cheap, either. At $16, the stock is pricing in continued execution. It has already closed much of the gap to intrinsic value that existed at $9. The easy money has been made by whoever bought in that trough. What remains is the harder trade: determining whether execution over the next two to four quarters justifies further appreciation from current levels.

The most accurate description today: PATH is conditionally undervalued, with the condition being that net new ARR reaccelerates, AI deal mix holds above 75% of top deals, and management demonstrates that the coding agent and Maestro adoption are converting pilots to production revenue. If those three conditions are met over the next two quarters, the stock likely has room to run toward the 52-week high of $19.84 and potentially through it. If any of those conditions fail, the stock trades back toward fair value in the low $13s, where the analyst consensus currently sits.

Bull, Base, and Bear

Bull Case

UiPath is the governance and orchestration layer that enterprise AI cannot scale without. As hyperscalers ship more capable foundation models, the coordination problem grows larger, not smaller. Maestro is positioned as the neutral layer that routes work across models, maintains audit trails, and keeps humans appropriately in the loop. If enterprises converge on a single orchestration platform the way they converged on a single CRM or ERP vendor, UiPath’s installed base of 10,600 customers and 65% Fortune 500 penetration gives it a structural first-mover advantage. At that point, net retention climbs back toward the 115% to 120% range it held in 2021 and 2022, the AI deal expansion six-times effect compounds across the install base, and the stock re-rates materially higher than current levels.

The coding agent is a legitimate TAM expansion driver. If automating a new workflow drops from weeks of developer time to hours of natural-language prompting, hundreds of previously shelved automation projects become economically viable again. That increases consumption on the existing platform without requiring UiPath to win a single new logo.

Base Case

UiPath continues to grow revenue in the 10% to 15% range annually, ARR reaches the guided $2.06 billion by January 2027, and GAAP profitability is sustained. The stock trades in a range between current levels and the 52-week high over the next twelve months, with volatility around each quarterly report. Investors who bought near the lows have captured most of the recovery. Investors entering today at $16 generate a reasonable but not exceptional return over a two-year hold, conditional on consistent execution.

Bear Case

Net new ARR does not reaccelerate. The gap between 17% revenue growth and 12% ARR growth widens rather than closes, signaling that recognized revenue is pulling forward from backlog while new bookings disappoint. Microsoft and Google bundle automation capabilities deeply enough into existing enterprise contracts that mid-market buyers stop evaluating UiPath entirely. Net retention slips back below 105%. The September 3 earnings report delivers revenue in line with guidance but ARR below the $1.929 billion to $1.934 billion target, and the stock gives back a meaningful portion of the recent rally, returning toward the low $12s or high $11s where the consensus had been anchored.

The 21.8% short interest matters here. If the bear case plays out, the stock does not need new sellers to fall. It needs buyers to step back. At that float and short interest, a disappointing quarter can move the stock more than the fundamentals alone would suggest.

The Action Plan

This is not a buy-it-all-today situation. It is a watch-and-scale situation, and the logic is straightforward.

The September 3 earnings report is the next major data point. Management guided Q2 revenue of $395 million to $400 million and Q2 ARR of $1.929 billion to $1.934 billion. Those are the thresholds. A beat on both, accompanied by an upward full-year revision and continued strength in AI deal mix, likely pushes PATH through the 52-week high. A miss on ARR specifically, even a modest one, will test whether the recent rally was fundamental or momentum-driven.

• For investors with no position: Waiting until September 3 is rational. The stock has already moved 75% off its lows. The risk/reward of entering before the report is less favorable than it was at $10. If Q2 confirms the thesis, there is still likely a multi-quarter runway ahead. Missing the next 10% to 15% to avoid the binary event risk is a reasonable trade.
• For investors with a small position established lower: Holding through the report makes sense if you believe in the multi-year orchestration thesis. Consider sizing up on any post-report weakness that is not driven by structural deterioration in ARR or net retention.
• Trim level to watch: If PATH clears $19.84 without a corresponding acceleration in ARR growth, the stock is pricing in perfection. That is a reasonable point to reduce exposure and wait for the next entry.
• Invalidation signal: Two consecutive quarters of declining net new ARR, or net retention below 105%, would suggest the expansion cycle is stalling rather than inflecting. That changes the thesis materially.

The Cheap Investor Scorecard

The Bottom Line

Markets misprice companies most aggressively when a temporary problem gets extrapolated permanently. That is what happened to UiPath between 2022 and early 2026. Growth decelerated, profitability lagged, and hyperscaler competition loomed large enough to convince the market this was a dying RPA vendor rather than an emerging enterprise orchestration platform.

The evidence today does not support the worst version of that thesis. UiPath has GAAP profits, $375 million in annual free cash flow, an 83% gross margin, a net cash balance of $1.3 billion, and AI components in 80% of its largest deals. Those are the characteristics of a business that is repositioning, not declining.

But here is the honest framing for a bargain hunter: the cheapest entry has passed. If you bought at $9 or $10, you have already captured the widest part of the mispricing. What remains at $16 is a conditional value proposition. If net new ARR reaccelerates and AI deal expansion continues to expand average contract sizes, PATH likely has a path toward $20 and beyond over the next twelve to eighteen months. If execution disappoints and the ARR growth gap widens, the stock retreats to where the analyst consensus has sat all along.

September 3 is not a make-or-break moment for the company. UiPath will still be generating hundreds of millions in free cash flow regardless of what the quarter says. But it is a make-or-break moment for the thesis that the market has re-rated this stock for the right reasons rather than the momentum. Watch the ARR number closely. Watch the AI deal mix. And watch the guidance tone for any sign that management believes the expansion cycle is accelerating.

Patient bargain hunters do not chase. They identify the conditions that would confirm or deny a thesis, and they act accordingly. For PATH, those conditions are three weeks away.

Stay disciplined,
The Cheap Investor